Bespoke Extracts (BSPK) Total Liabilities (2011 - 2025)
Bespoke Extracts (BSPK) reported Total Liabilities of $2.9 million for Q3 2025, up 8.39% on a YoY basis from $2.7 million in Q3 2024, and up 3.02% sequentially from $2.8 million in Q2 2025.
Bespoke Extracts (BSPK) Total Liabilities (2011 - 2025) Analysis & Trends
Bespoke Extracts (BSPK) has 15 years of Total Liabilities data on file, last reported at $2.9 million in Q3 2025.
- For the quarter ending Q3 2025, Total Liabilities rose 8.39% year-over-year to $2.9 million; the trailing twelve-month figure through Sep 2025 stood at $2.9 million (up 8.39% YoY), and the FY2024 full-year result was $2.5 million, up 17.9% from the prior year.
- Total Liabilities advanced to $2.9 million in Q3 2025, from $2.8 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $2.9 million in Q3 2025 to a low of $67106.0 in Q4 2021.
- A 5-year average of $1.6 million and a median of $1.8 million in 2023 frame the typical range for Total Liabilities.
- Peak annual rise in Total Liabilities reached 530.08% in 2021, while the deepest fall reached 79.98% in 2021.
- Tracing BSPK's Total Liabilities over 5 years: stood at $67106.0 in 2021, then jumped by 1511.91% to $1.1 million in 2022, then soared by 92.19% to $2.1 million in 2023, then rose by 17.9% to $2.5 million in 2024, then increased by 17.95% to $2.9 million in 2025.
- Business Quant data shows BSPK's Total Liabilities at $2.9 million in Q3 2025, $2.8 million in Q2 2025, and $2.6 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 21.48 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 31.81 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.92 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 51.53 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 813.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 22.18 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.50 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.72 Bn |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 | 2.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2.89 Mn |
| Jun 30, 2025 | 2.81 Mn |
| Mar 31, 2025 | 2.58 Mn |
| Dec 31, 2024 | 2.45 Mn |
| Sep 30, 2024 | 2.67 Mn |
| Jun 30, 2024 | 2.54 Mn |
| Mar 31, 2024 | 2.33 Mn |
| Dec 31, 2023 | 2.08 Mn |
| Sep 30, 2023 | 1.94 Mn |
| Jun 30, 2023 | 1.79 Mn |
| Mar 31, 2023 | 1.45 Mn |
| Dec 31, 2022 | 1.08 Mn |
| Sep 30, 2022 | 750,602.00 |
| Jun 30, 2022 | 544,726.00 |
| Mar 31, 2022 | 506,119.00 |
| Nov 30, 2021 | 67,106.00 |
| Aug 31, 2021 | 124,520.00 |
| May 31, 2021 | 293,157.00 |
| Feb 28, 2021 | 646,520.00 |
| Nov 30, 2020 | 335,247.00 |